ColoWatch is bringing together clinical, business, and technical leaders who are committed to delivering reliable, standardized performance and interpretation of virtual colonoscopy studies.
A virtual colonoscopy study at any facility in the ColoWatch network will be performed with the same protocol and quality-control tools developed by ColoWatch. Each study will be delivered securely through the cloud to our network of board-certified radiologists expertly trained in using ColoWatch's 3D visualization software.
The result: reproducible, accurate interpretation of virtual colonoscopy studies by the best clinicians in the business.
Over the last 25 years, virtual colonoscopy has been proven to be a highly accurate, extremely safe, convenient, and cost-effective method of colorectal cancer prevention and screening. It can reliably find relevant polyps that are the precursor of colorectal cancer while safely confirming the absence of any problem in over 90% of those screened.
The powerful combination of these attributes supports virtual colonoscopy being the screening study of choice for colorectal cancer in average risk individuals. As an added benefit, virtual colonoscopy ultra low dose CT studies can, in some but not all patients, identify other unsuspected important medical conditions such as cancers outside the colon, osteoporosis, and some cardiovascular disease.
Widespread implementation will save thousands of lives in the United States alone and generate billions of dollars of savings for the healthcare system annually.
© 2024 COLOWATCH. All rights reserved.Privacy Policy